Improving eye disease treatment through data sharing and analysis
Official title: EyeMatics - Eye Diseases "Treated" With Interoperable Medical Informatics
Run by University Hospital Muenster · NCT06810011 · Data updated 2026-11-12
This study is trying to see if sharing and analyzing eye disease treatment data can help doctors provide better personalized care for patients receiving intravitreal injections.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | University Hospital Muenster Academic / other |
| Locations | 6 sites (Chemnitz, Saxony and 5 other locations) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | February 29, 2028 |
| Study ends | February 29, 2028 |
| Registry record updated | February 5, 2025 |
| Trial ID | NCT06810011 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients undergoing intravitreal injections for eye diseases.
✕Probably not a fit
Patients not receiving intravitreal injections or those with unrelated eye conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The EyeMatics project aims to create a sustainable infrastructure for integrating and sharing clinical research data to enhance personalized medicine in ophthalmology. By collaborating with multiple ophthalmological centers of excellence in Germany, the initiative focuses on understanding the therapeutic success of eye diseases treated with intravitreal injections. The project will develop a web-based dashboard for visualizing and analyzing real clinical data, incorporating patient feedback to improve quality of life and treatment outcomes.
Why it matters
Potential benefit: If successful, this project could lead to more effective and personalized treatments for patients with eye diseases.
How similar studies have gone: Other studies utilizing data sharing and artificial intelligence in healthcare have shown promise, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * OPS code: "5-156.9 Injection of drugs into the posterior segment of the eye"
Where it's running
-
Klinikum Chemnitz gGmbH
Chemnitz, Saxony, Germany Recruiting -
Universitätsklinikum Aachen, AöR
Aachen, Germany Recruiting -
Universitätsmedizin Greifswald
Greifswald, Germany Recruiting -
Universität Leipzig
Leipzig, Germany Recruiting -
Universität Münster
Münster, Germany Recruiting -
Universitätsklinikum Tübingen
Tübingen, Germany Recruiting
Study contacts
- Study coordinator: Nicole Eter, Prof. Dr.
- Email: eter@uni-muenster.de
- Phone: 00492518356004
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Switching from ranibizumab to aflibercept for eye conditions
This study is testing if switching patients with certain eye conditions from one medication to another can help improve their vision.
-
Endohepatology-based reclassification of treatment indication in high-risk MASLD
This study tests whether an endohepatology assessment can change treatment decisions for adults with high-risk MASLD.
-
How EMST helps swallowing in Parkinson's patients
This study tests whether four weeks of expiratory muscle strength training can improve swallowing in people with Parkinson’s-related dysphagia.
-
Neoadjuvant prehabilitation to improve physical and mental recovery for people with solid tumors
This trial tests whether a supervised exercise program plus structured psycho-oncological support before surgery or radiotherapy helps adults with solid tumors stay fitter and feel better than standard care.
-
How bacteria beneath the gums change after resective, regenerative, or peri-implant surgery
We will test whether three types of gum and implant surgery cause different changes in the bacteria beneath the gums in adults with periodontitis or peri-implantitis.
-
Surgical outcomes and quality of life after removal of juxtamedullary spinal tumors
This project will collect information from adults with juxtamedullary (intradural, extramedullary) spinal tumors to see which surgical approaches and perioperative practices are linked to better recovery, function, and quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.